The Future of Pharmaceutical Psychedelics in Mental Health Treatment

Originally posted with the Opioid Matrix Dec 2022

In this episode we speak with Erica Siegal, a licensed clinical social worker, professional harm reductionist community organizer, psychedelic-assisted psychotherapist, and founder of NEST Harm Reduction Consulting in California. She worked as a psychotherapist researcher on the phase two and phase three FDA approved MDMA assisted psychotherapy clinical trials from 2014 to 2019. 

Join us as we discuss: 

  • Emerging findings about psychedelic treatments for individuals with mental health issues 

  • The pace of psychedelic substance regulation on a state and federal level  

  • Psychedelic substance interventions in the case of opioid addiction treatments

Next
Next

Plant Medicine Podcast: Psychedelic Harm Reduction with Erica Siegal, LCSW